Abstract
The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France, June 5–10, 2011), 12th (Comandatuba, Brazil, August 19–23, 2013), and 13th (Vancouver, British Columbia, Canada, October 5–10, 2015) meetings of the Banff Conference on Allograft Pathology. Discussion continued online. The primary goal was to introduce guidelines and consensus criteria for the diagnosis of liver allograft antibodymediated rejection and provide a comprehensive update of all Banff Schema recommendations. Included are new recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization. In an effort to create a single reference document, previous unchanged criteria are also included.
Original language | English (US) |
---|---|
Pages (from-to) | 2816-2835 |
Number of pages | 20 |
Journal | American Journal of Transplantation |
Volume | 16 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2016 |
ASJC Scopus subject areas
- Immunology and Allergy
- Transplantation
- Pharmacology (medical)